• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻窦癌患者的发病率和生存率:基于人群的历史数据分析。

Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data.

机构信息

Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Head Neck. 2012 Jun;34(6):877-85. doi: 10.1002/hed.21830. Epub 2011 Aug 24.

DOI:10.1002/hed.21830
PMID:22127982
Abstract

BACKGROUND

The present study uses population-based data from the Surveillance, Epidemiology, and End Results (SEER) database to evaluate the behavior of sinonasal tumors.

METHODS

Data for all sinonasal malignancies reported between 1973 and 2006 (n = 6739) were extracted from the database. Time-dependent trends in incidence and survival were analyzed by linear regression.

RESULTS

The overall incidence of sinonasal cancer was 0.556 cases per 100,000 population per year with a male:female ratio of 1.8:1. The most common histologies were squamous cell carcinoma (51.6%) and adenocarcinoma (12.6%), whereas the most common primary sites were the nasal cavity (43.9%) and maxillary sinus (35.9%). The incidence of sinonasal cancer remained relatively stable during the study period. No significant changes in overall relative survival were noted. The best relative survival was noted in patients treated with surgery or a combination of surgery and radiotherapy.

CONCLUSIONS

The prognosis of patients with sinonasal cancer is generally poor, and has not changed substantially over the last 3 decades.

摘要

背景

本研究利用基于人群的监测、流行病学和最终结果(SEER)数据库的数据来评估鼻旁窦肿瘤的行为。

方法

从数据库中提取 1973 年至 2006 年间报告的所有鼻旁窦恶性肿瘤的数据。通过线性回归分析发病率和生存率的时间依赖性趋势。

结果

鼻旁窦癌的总体发病率为每年每 100,000 人口 0.556 例,男女比例为 1.8:1。最常见的组织学类型是鳞状细胞癌(51.6%)和腺癌(12.6%),而最常见的原发部位是鼻腔(43.9%)和上颌窦(35.9%)。在研究期间,鼻旁窦癌的发病率相对稳定。总相对生存率没有显著变化。接受手术或手术联合放疗治疗的患者的相对生存率最好。

结论

鼻旁窦癌患者的预后一般较差,在过去 30 年中没有发生实质性变化。

相似文献

1
Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data.鼻窦癌患者的发病率和生存率:基于人群的历史数据分析。
Head Neck. 2012 Jun;34(6):877-85. doi: 10.1002/hed.21830. Epub 2011 Aug 24.
2
Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8).鼻腔、中耳和副鼻窦癌症-15 年按年龄、性别、种族、分期、分级、队列进入时间-时期、疾病持续时间和解剖学原发部位比较生存和死亡率分析:2000-2017 年诊断年的 13404 例病例的系统评价:(NCI SEER*Stat 8.3.8)。
J Insur Med. 2024 Jul 1;51(2):77-91. doi: 10.17849/insm-51-2-77-91.1.
3
Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).局部晚期鼻旁窦恶性肿瘤的确定性碳离子放射治疗:日本碳离子放射肿瘤学研究组(J-CROS)多中心研究的亚组分析。
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):353-361. doi: 10.1016/j.ijrobp.2018.05.074. Epub 2018 Jun 5.
4
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment.鼻腔和鼻窦癌:诊断与治疗。
Curr Oncol Rep. 2024 Sep;26(9):1057-1069. doi: 10.1007/s11912-024-01566-x. Epub 2024 Jun 27.
5
Recurrence patterns of sinonasal cancers after a 5-year disease-free period.5 年无病生存期后鼻窦癌的复发模式。
Laryngoscope. 2019 Nov;129(11):2451-2457. doi: 10.1002/lary.27866. Epub 2019 Feb 22.
6
Sinonasal malignancies: A population-based analysis of site-specific incidence and survival.鼻窦恶性肿瘤:基于人群的特定部位发病率和生存率分析。
Laryngoscope. 2015 Nov;125(11):2491-7. doi: 10.1002/lary.25465. Epub 2015 Jul 30.
7
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009.基于监测、流行病学和最终结果数据的鼻窦鳞状细胞癌发病率和生存率,1973 年至 2009 年。
Cancer. 2013 Jul 15;119(14):2602-10. doi: 10.1002/cncr.28108. Epub 2013 May 14.
8
A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.鼻窦恶性肿瘤治疗方式的全面比较分析
Cancer. 2017 Aug 15;123(16):3040-3049. doi: 10.1002/cncr.30686. Epub 2017 Apr 3.
9
A multi-institutional retrospective study of 340 cases of sinonasal malignant tumor.一项多机构回顾性研究纳入了 340 例鼻窦恶性肿瘤病例。
Auris Nasus Larynx. 2024 Feb;51(1):86-98. doi: 10.1016/j.anl.2023.05.002. Epub 2023 May 27.
10
A population-based comparison of European and North American sinonasal cancer survival.一项基于人群的欧洲和北美鼻窦癌生存率比较。
Auris Nasus Larynx. 2018 Aug;45(4):815-824. doi: 10.1016/j.anl.2017.09.009. Epub 2017 Oct 19.

引用本文的文献

1
Antitumor Effects of Metformin in Squamous Cell Carcinoma under Leptin Treatment Conditions.瘦素治疗条件下二甲双胍对鳞状细胞癌的抗肿瘤作用
Prev Nutr Food Sci. 2025 Aug 31;30(4):312-322. doi: 10.3746/pnf.2025.30.4.312.
2
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases.EZH2在鼻部疾病中的作用机制及治疗意义
Clin Rev Allergy Immunol. 2025 May 5;68(1):46. doi: 10.1007/s12016-025-09058-x.
3
Sinonasal Intestinal-Type Adenocarcinoma in the Netherlands: A Nationwide Study (2008-2022).荷兰鼻窦肠型腺癌:一项全国性研究(2008 - 2022年)
Head Neck. 2025 Sep;47(9):2531-2540. doi: 10.1002/hed.28171. Epub 2025 Apr 22.
4
Unravelling the mystery of maxillary sinus malignancy initiated with periapical radiograph: A case report.通过根尖片揭示上颌窦恶性肿瘤之谜:一例报告。
Bioinformation. 2024 Dec 31;20(12):1780-1783. doi: 10.6026/9732063002001780. eCollection 2024.
5
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163.新辅助化疗联合手术与单纯手术治疗T3和T4a期鼻及鼻窦鳞状细胞癌以保留器官:ECOG-ACRIN EA3163研究
Clin Cancer Res. 2025 Jun 13;31(12):2339-2346. doi: 10.1158/1078-0432.CCR-24-4085.
6
[70/m, swelling of the nasal bone : Preparation for the medical specialist examination: part 48].[70岁男性,鼻骨肿胀:医学专科检查准备:第48部分]
HNO. 2025 May;73(Suppl 1):63-66. doi: 10.1007/s00106-025-01569-5. Epub 2025 Apr 3.
7
Identifying chemotherapy beneficiaries in nasal and paranasal sinus cancers: epidemiological trends and machine learning insights.确定鼻及鼻窦癌化疗受益人群:流行病学趋势与机器学习见解
Eur J Med Res. 2025 Apr 1;30(1):218. doi: 10.1186/s40001-025-02425-6.
8
Prognostic role of p16 overexpression in sinonasal squamous cell carcinoma: A retrospective analysis of Alberta patients.p16过表达在鼻窦鳞状细胞癌中的预后作用:对艾伯塔省患者的回顾性分析
World J Otorhinolaryngol Head Neck Surg. 2024 Mar 22;11(1):52-56. doi: 10.1002/wjo2.154. eCollection 2025 Mar.
9
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.鼻窦恶性肿瘤:ESMO-EURACAN诊断、治疗及随访临床实践指南
ESMO Open. 2025 Feb;10(2):104121. doi: 10.1016/j.esmoop.2024.104121. Epub 2025 Feb 6.
10
A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994-2018.一项基于人群的西班牙东北部头颈部上皮癌发病率趋势研究,1994 - 2018年
Clin Transl Oncol. 2025 Feb 19. doi: 10.1007/s12094-025-03855-8.